Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Surgical and Surgeon-Related Factors Related to Long-Term Survival in Esophageal Cancer: A Review.

Markar SR, Lagergren J.

Ann Surg Oncol. 2019 Nov 5. doi: 10.1245/s10434-019-07966-9. [Epub ahead of print] Review.

PMID:
31691111
2.

Comparison of Surgical Intervention and Mortality for Seven Surgical Emergencies in England and the United States.

Markar SR, Vidal-Diez A, Patel K, Maynard W, Tukanova K, Murray A, Holt PJ, Karthikesalingam A, Hanna GB.

Ann Surg. 2019 Nov;270(5):806-812. doi: 10.1097/SLA.0000000000003518.

PMID:
31567504
3.

Benefits of barbed suture utilisation in gastrointestinal anastomosis: a systematic review and meta-analysis.

Wiggins T, Majid MS, Markar SR, Loy J, Agrawal S, Koak Y.

Ann R Coll Surg Engl. 2019 Sep 11:e1-e7. doi: 10.1308/rcsann.2019.0106. [Epub ahead of print]

PMID:
31508982
4.

An international comparison of the utilisation of and outcomes from minimal access surgery for the treatment of common abdominal surgical emergencies.

Tukanova K, Markar SR, Jamel S, Vidal-Diez A, Hanna GB.

Surg Endosc. 2019 Aug 19. doi: 10.1007/s00464-019-06980-y. [Epub ahead of print]

PMID:
31428852
5.

An International Comparison of the Management of Gastrointestinal Surgical Emergencies in Octogenarians-England versus United States: A National Population-based Cohort Study.

Markar SR, Vidal-Diez A, Holt PJ, Karthikesalingam A, Hanna GB.

Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003396. [Epub ahead of print]

PMID:
31188204
6.

Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study.

Klevebro F, Elliott JA, Slaman A, Vermeulen BD, Kamiya S, Rosman C, Gisbertz SS, Boshier PR, Reynolds JV, Rouvelas I, Hanna GB, van Berge Henegouwen MI, Markar SR.

Ann Surg Oncol. 2019 Sep;26(9):2864-2873. doi: 10.1245/s10434-019-07478-6. Epub 2019 Jun 10.

7.

Clinical Application of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis-In Reply.

Hanna GB, Boshier PR, Markar SR.

JAMA Oncol. 2019 Jul 1;5(7):1069. doi: 10.1001/jamaoncol.2019.1158. No abstract available.

PMID:
31120476
8.

The evolution of fast track protocols after oesophagectomy.

Jamel S, Tukanova K, Markar SR.

J Thorac Dis. 2019 Apr;11(Suppl 5):S675-S684. doi: 10.21037/jtd.2018.11.63. Review.

9.

Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis.

Guidozzi N, Wiggins T, Ahmed AR, Hanna GB, Markar SR.

Dis Esophagus. 2019 May 9. pii: doz031. doi: 10.1093/dote/doz031. [Epub ahead of print]

PMID:
31069388
10.

Management of achalasia in 2019.

Zaninotto G, Leusink A, Markar SR.

Curr Opin Gastroenterol. 2019 Apr 24. doi: 10.1097/MOG.0000000000000544. [Epub ahead of print]

PMID:
31033769
11.

Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer. Reply.

Markar SR, Dabakuyo-Yonli TS, Piessen G.

N Engl J Med. 2019 Apr 25;380(17):e28. doi: 10.1056/NEJMc1901650. No abstract available.

PMID:
31018084
12.

Optimum timing of emergency cholecystectomy for acute cholecystitis in England: population-based cohort study.

Wiggins T, Markar SR, MacKenzie H, Faiz O, Mukherjee D, Khoo DE, Purkayastha S, Beckingham I, Hanna GB.

Surg Endosc. 2019 Aug;33(8):2495-2502. doi: 10.1007/s00464-018-6537-x. Epub 2019 Apr 4.

13.

Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy: A Systematic Review and Meta-analysis.

Gottlieb-Vedi E, Kauppila JH, Malietzis G, Nilsson M, Markar SR, Lagergren J.

Ann Surg. 2019 Feb 21. doi: 10.1097/SLA.0000000000003252. [Epub ahead of print]

PMID:
30817355
14.

Incidence and risk factors for esophageal cancer following achalasia treatment: national population-based case-control study.

Markar SR, Wiggins T, MacKenzie H, Faiz O, Zaninotto G, Hanna GB.

Dis Esophagus. 2019 May 1;32(5). pii: doy106. doi: 10.1093/dote/doy106.

PMID:
30809653
15.

Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer.

Mariette C, Markar SR, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, D'Journo XB, Brigand C, Perniceni T, Carrère N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Bonnetain F, Piessen G; Fédération de Recherche en Chirurgie (FRENCH) and French Eso-Gastric Tumors (FREGAT) Working Group.

N Engl J Med. 2019 Jan 10;380(2):152-162. doi: 10.1056/NEJMoa1805101.

PMID:
30625052
16.

Cancer Risk Following Bariatric Surgery-Systematic Review and Meta-analysis of National Population-Based Cohort Studies.

Wiggins T, Antonowicz SS, Markar SR.

Obes Surg. 2019 Mar;29(3):1031-1039. doi: 10.1007/s11695-018-3501-8. Review.

PMID:
30591985
17.

A population-based cohort study examining the risk of abdominal cancer after endovascular abdominal aortic aneurysm repair.

Markar SR, Vidal-Diez A, Sounderajah V, Mackenzie H, Hanna GB, Thompson M, Holt P, Lagergren J, Karthikesalingam A.

J Vasc Surg. 2019 Jun;69(6):1776-1785.e2. doi: 10.1016/j.jvs.2018.09.058. Epub 2018 Dec 21.

PMID:
30583890
18.

Reintervention After Antireflux Surgery for Gastroesophageal Reflux Disease in England.

Markar SR, Arhi C, Wiggins T, Vidal-Diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB.

Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003131. [Epub ahead of print]

PMID:
30499807
19.

The surgical management of non-malignant aerodigestive fistula.

Qureshi YA, Muntzer Mughal M, Markar SR, Mohammadi B, George J, Hayward M, Lawrence D.

J Cardiothorac Surg. 2018 Nov 15;13(1):113. doi: 10.1186/s13019-018-0799-1.

20.

Acute upper gastrointestinal bleeding.

Sverdén E, Markar SR, Agreus L, Lagergren J.

BMJ. 2018 Oct 25;363:k4023. doi: 10.1136/bmj.k4023. No abstract available.

PMID:
30361444
21.

Cancer risk after bariatric surgery - is colorectal cancer a special case?

Hull MA, Markar SR, Morris EJA.

Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):653-654. doi: 10.1038/s41575-018-0070-1. No abstract available.

PMID:
30267023
22.

The 2018 ISDE achalasia guidelines.

Zaninotto G, Bennett C, Boeckxstaens G, Costantini M, Ferguson MK, Pandolfino JE, Patti MG, Ribeiro U Jr, Richter J, Swanstrom L, Tack J, Triadafilopoulos G, Markar SR, Salvador R, Faccio L, Andreollo NA, Cecconello I, Costamagna G, da Rocha JRM, Hungness ES, Fisichella PM, Fuchs KH, Gockel I, Gurski R, Gyawali CP, Herbella FAM, Holloway RH, Hongo M, Jobe BA, Kahrilas PJ, Katzka DA, Dua KS, Liu D, Moonen A, Nasi A, Pasricha PJ, Penagini R, Perretta S, Sallum RAA, Sarnelli G, Savarino E, Schlottmann F, Sifrim D, Soper N, Tatum RP, Vaezi MF, van Herwaarden-Lindeboom M, Vanuytsel T, Vela MF, Watson DI, Zerbib F, Gittens S, Pontillo C, Vermigli S, Inama D, Low DE.

Dis Esophagus. 2018 Sep 1;31(9). doi: 10.1093/dote/doy071.

PMID:
30169645
23.

Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.

Hanna GB, Boshier PR, Markar SR, Romano A.

JAMA Oncol. 2019 Jan 1;5(1):e182815. doi: 10.1001/jamaoncol.2018.2815. Epub 2019 Jan 10. Erratum in: JAMA Oncol. 2019 Jul 1;5(7):1070.

24.

The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.

Markar SR, Arhi C, Leusink A, Vidal-Diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB.

Ann Surg. 2018 Nov;268(5):861-867. doi: 10.1097/SLA.0000000000002890.

25.

Evolution in the management of acute cholecystitis in the elderly: population-based cohort study.

Wiggins T, Markar SR, Mackenzie H, Jamel S, Askari A, Faiz O, Karamanakos S, Hanna GB.

Surg Endosc. 2018 Oct;32(10):4078-4086. doi: 10.1007/s00464-018-6092-5. Epub 2018 Jul 25.

26.

Laparoscopic surgery for perforated peptic ulcer: an English national population-based cohort study.

Leusink A, Markar SR, Wiggins T, Mackenzie H, Faiz O, Hanna GB.

Surg Endosc. 2018 Sep;32(9):3783-3788. doi: 10.1007/s00464-018-6058-7. Epub 2018 Jul 19.

27.

Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer.

Markar SR, Brodie B, Chin ST, Romano A, Spalding D, Hanna GB.

Br J Surg. 2018 Oct;105(11):1493-1500. doi: 10.1002/bjs.10909. Epub 2018 Jul 18.

28.

Obesity surgery and risk of cancer.

Mackenzie H, Markar SR, Askari A, Faiz O, Hull M, Purkayastha S, Møller H, Lagergren J.

Br J Surg. 2018 Nov;105(12):1650-1657. doi: 10.1002/bjs.10914. Epub 2018 Jul 13.

29.

The influence of hospital volume upon clinical management and outcomes of esophageal achalasia: an English national population-based cohort study.

Wiggins T, Markar SR, MacKenzie H, Faiz O, Zaninotto G, Hanna GB.

Dis Esophagus. 2018 Sep 1;31(9). doi: 10.1093/dote/doy045.

PMID:
29985997
30.

Response "Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection".

Markar SR, Lagergren J.

Ann Surg. 2019 Jan;269(1):e7. doi: 10.1097/SLA.0000000000002841. No abstract available.

PMID:
29864096
31.

Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis.

Boshier PR, Heneghan R, Markar SR, Baracos VE, Low DE.

Dis Esophagus. 2018 Aug 1;31(8). doi: 10.1093/dote/doy047. Review.

PMID:
29846548
32.

Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer.

Markar SR, Wiggins T, Antonowicz S, Chin ST, Romano A, Nikolic K, Evans B, Cunningham D, Mughal M, Lagergren J, Hanna GB.

JAMA Oncol. 2018 Jul 1;4(7):970-976. doi: 10.1001/jamaoncol.2018.0991.

33.

Prognostic Value of Lymph Node Yield on Overall Survival in Esophageal Cancer Patients: A Systematic Review and Meta-analysis.

Visser E, Markar SR, Ruurda JP, Hanna GB, van Hillegersberg R.

Ann Surg. 2019 Feb;269(2):261-268. doi: 10.1097/SLA.0000000000002824.

PMID:
29794846
34.

Population-based cohort study of surgical myotomy and pneumatic dilatation as primary interventions for oesophageal achalasia.

Markar SR, Mackenzie H, Askari A, Faiz O, Hoare J, Zaninotto G, Hanna GB.

Br J Surg. 2018 Jul;105(8):1028-1035. doi: 10.1002/bjs.10805. Epub 2018 Mar 30.

35.

Variation in Exhaled Acetone and Other Ketones in Patients Undergoing Bariatric Surgery: a Prospective Cross-sectional Study.

Boshier PR, Fehervari M, Markar SR, Purkayastha S, Spanel P, Smith D, Hanna GB.

Obes Surg. 2018 Aug;28(8):2439-2446. doi: 10.1007/s11695-018-3180-5.

36.

Complications during neoadjuvant therapy and prognosis following surgery for esophageal cancer.

Markar SR, Johar A, Maisey N, Lagergren P, Lagergren J.

Dis Esophagus. 2018 May 1;31(5). doi: 10.1093/dote/dox151.

37.

Effect of perioperative blood transfusion on the long-term survival of patients undergoing esophagectomy for esophageal cancer: a systematic review and meta-analysis.

Boshier PR, Ziff C, Adam ME, Fehervari M, Markar SR, Hanna GB.

Dis Esophagus. 2018 Apr 1;31(4). doi: 10.1093/dote/dox134. Review.

PMID:
29267869
38.

Breath Volatile Organic Compound Profiling of Colorectal Cancer Using Selected Ion Flow-tube Mass Spectrometry.

Markar SR, Chin ST, Romano A, Wiggins T, Antonowicz S, Paraskeva P, Ziprin P, Darzi A, Hanna GB.

Ann Surg. 2019 May;269(5):903-910. doi: 10.1097/SLA.0000000000002539.

39.

Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions.

Markar SR, Mackenzie H, Wiggins T, Askari A, Karthikesalingam A, Faiz O, Griffin SM, Birkmeyer JD, Hanna GB.

Br J Surg. 2018 Jan;105(1):113-120. doi: 10.1002/bjs.10640. Epub 2017 Nov 20.

40.

Induced Bias Due to Crossover Within Randomized Controlled Trials in Surgical Oncology: A Meta-regression Analysis of Minimally Invasive versus Open Surgery for the Treatment of Gastrointestinal Cancer.

Garas G, Markar SR, Malietzis G, Ashrafian H, Hanna GB, Zacharakis E, Jiao LR, Argiris A, Darzi A, Athanasiou T.

Ann Surg Oncol. 2018 Jan;25(1):221-230. doi: 10.1245/s10434-017-6210-y. Epub 2017 Nov 6. Review.

41.

Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review.

Huddy JR, Huddy FMS, Markar SR, Tucker O.

Dis Esophagus. 2018 Jan 1;31(1):1-11. doi: 10.1093/dote/dox110. Review. Erratum in: Dis Esophagus. 2018 Apr 1;31(4):.

42.

Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy.

Markar SR, Gronnier C, Pasquer A, Duhamel A, Behal H, Théreaux J, Gagnière J, Lebreton G, Brigand C, Renaud F, Piessen G, Meunier B, Collet D, Mariette C; FREGAT Working Group—FRENCH—AFC.

Ann Surg Oncol. 2017 Dec;24(13):3911-3920. doi: 10.1245/s10434-017-6088-8. Epub 2017 Sep 25.

43.

Component analysis of enhanced recovery pathways for esophagectomy.

Markar SR, Naik R, Malietzis G, Halliday L, Athanasiou T, Moorthy K.

Dis Esophagus. 2017 Oct 1;30(10):1-10. doi: 10.1093/dote/dox090. Review.

44.

Salvage esophagectomy: safe therapeutic strategy?

Jamel S, Markar SR.

J Thorac Dis. 2017 Jul;9(Suppl 8):S799-S808. doi: 10.21037/jtd.2017.05.09. Review.

45.

Enhanced recovery protocols after oesophagectomy.

Halliday LJ, Markar SR, Doran SLF, Moorthy K.

J Thorac Dis. 2017 Jul;9(Suppl 8):S781-S784. doi: 10.21037/jtd.2017.07.16. Review.

46.

Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis.

Jamel S, Markar SR, Malietzis G, Acharya A, Athanasiou T, Hanna GB.

Gastric Cancer. 2018 Jan;21(1):10-18. doi: 10.1007/s10120-017-0749-y. Epub 2017 Aug 4. Review.

47.

Effect of Esophageal Cancer Surgeon Volume on Management and Mortality From Emergency Upper Gastrointestinal Conditions: Population-based Cohort Study.

Markar SR, Mackenzie H, Askari A, Faiz O, Hanna GB.

Ann Surg. 2017 Nov;266(5):847-853. doi: 10.1097/SLA.0000000000002387.

48.

Meta-analysis of health-related quality of life after minimally invasive versus open oesophagectomy for oesophageal cancer.

Kauppila JH, Xie S, Johar A, Markar SR, Lagergren P.

Br J Surg. 2017 Aug;104(9):1131-1140. doi: 10.1002/bjs.10577. Epub 2017 Jun 20. Review.

PMID:
28632926
49.

Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma.

Erridge S, Pucher PH, Markar SR, Malietzis G, Athanasiou T, Darzi A, Sodergren MH, Jiao LR.

Br J Surg. 2017 Oct;104(11):1433-1442. doi: 10.1002/bjs.10597. Epub 2017 Jun 19. Review.

50.

Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma.

Acharya A, Markar SR, Sodergren MH, Malietzis G, Darzi A, Athanasiou T, Khan AZ.

Br J Surg. 2017 Jun;104(7):814-822. doi: 10.1002/bjs.10563. Review.

Supplemental Content

Loading ...
Support Center